Sunday, December 7, 2025

Latest

Apple: Analysts Anticipate Q3 Revenues Of $73.3 Billion

Apple (NASDAQ: AAPL) will be reporting their fiscal third quarter on July 27th after market close. Analysts have a consensus $159.98 12-month price target on the company, via a total of 41 analysts, with 12 analysts having strong buy ratings. 21 analysts meanwhile have buy ratings, 7 have hold ratings, and one has a strong sell on the company. The street high comes from Wedbush Securities with a $185 price target, and the lowest target sits at $125 from Wolfe Research.

25 analysts have revenue estimates for the third quarter. The mean revenue estimate between all 25 analysts is $73.276 billion; this number has been revised upwards from $66.284 billion at the start of the year. The highest revenue estimate is $77.054 billion, while the lowest is $65.682 billion.

Onto EBITDA estimates, there are currently only 9 analysts who have third-quarter EBITDA estimates. The mean is currently $22.516 billion, with this number having been revised up from $18.4 billion at the start of the year. Street high is a $24.44 billion EBITDA estimate and the lowest is $18.868 billion.

Analysts estimate that quarterly earnings per share will come in at $1.01, with this number being revised up from $0.76 at the start of the year. Street high is currently $1.16 and the lowest estimate is $0.82 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the World’s Biggest Gold Deposits Are Stuck | Rudi Fronk – Seabridge Gold

First Mining: Springpole Sees NPV Rise To $2.1 Billion

Have Metals Peaked? The Rotation Is Already Underway | Brayden Sutton

Recommended

Emerita Resources Awards Contract For Pre-Feasibility Study On Iberian Belt West Project

Selkirk Copper Appoints Two Members Of Selkirk First Nation To Leadership Team

Related News

Antibe Therapeutics: Canaccord Upgrades Price Target To $16.50

Earlier this week, Antibe Therapeutics (TSXV: ATE) announced a strategic licensing deal with Nuance Pharm...

Thursday, February 11, 2021, 04:07:00 PM

Ayr Strategies: PI Financial Initiates With $60 Price Target, Buy Rating

On January 20th, PI Financial became the fourth firm to cover Ayr Strategies’ (CSE: AYR.a)....

Sunday, January 24, 2021, 11:34:00 AM

Square: Consensus Price Target Climbs To $290 Following AfterPay Purchase

On August 2, a Sunday, Square Inc (NYSE: SQ) announced that they would be acquiring...

Tuesday, August 3, 2021, 12:44:00 PM

Teladoc Health: Numerous Analysts Raise Price Targets Following Q3 Earnings

Yesterday, Teladoc Health (NYSE: TDOC) reported its third quarter earnings results, reporting $228.8 million in...

Saturday, October 31, 2020, 02:02:00 PM

WeedMD: Canaccord Initiates Coverage With $0.60 Price Target

Yesterday morning, Canaccord Genuity initiated coverage on WeedMD Inc (TSXV: WMD) with a C$0.60 12-month...

Thursday, March 25, 2021, 11:47:00 AM